Stay informed with the latest updates for the inheritable blood disorders community. Industry Pfizer Highlights Phase 3 Trial Results of Marstacimab May 31, 2023 Industry FDA Requests Additional Information on Concizumab from Novo Nordisk May 5, 2023 Industry Sanofi Announces Publication of Two Phase 3 Fitusiran TrialsApr 6, 2023 Industry BioMarin Announces FDA’s Extended Review of Investigational…Mar 10, 2023 Industry uniQure Announces Published Trial Results for Approved Gene TherapyFeb 27, 2023 Industry FDA Approves ALTUVIIIO™ for Hemophilia A PatientsFeb 24, 2023 Industry Sanofi Announces New Efanesoctocog alfa Data Published in the NEJM Jan 30, 2023 Industry New FIX Chromogenic Assay Launched by Precision BioLogic Jan 18, 2023 Industry Biomarin Provides Hemophilia A Clinical Development Program UpdatesJan 10, 2023 Industry Takeda Announces Trial Results on Investigational Therapy for…Jan 10, 2023 Industry Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy…Jan 4, 2023 Industry Spark Announces SPK-8011 Updates at ASHDec 15, 2022 Industry BioMarin Shares Community Update for Valoctocogene RoxaparvovecOct 3, 2022 Industry Recruitment Reopened for Phase 3 AFFINE Gene Therapy Trial Sep 23, 2022 Industry FDA Grants Priority Review for Sanofi’s BIVV001Sep 6, 2022 Pagination First page Previous page Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page